Craig Chepke, MD, DFAPA discusses how chronic stress alters glutamatergic signaling and contributes to MDD.
Supported by an educational grant from Axsome Therapeutics, Inc.
All Podcasts
Kristian Dambrino, DNP, PMHNP-BC breaks down the pharmacology of this combination therapy.
Rakesh Jain, MD, MPH discusses common adverse effects and their impact on treatment discontinuation
Rakesh Jain, MD, MPH explores its unique mechanism and rapid effects on mood.
Rakesh Jain, MD, MPH discusses how astrocytes regulate glutamate and their impact on mood disorders.